Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.43 |
| ▸ | ATM | Q13315 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | PRKDC | P78527 | 3/20 | 0.36 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.34 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.33 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | PLA2G2A | P14555 | 3/20 | 0.32 |
| ▸ | PLA2G4A | P47712 | 3/20 | 0.32 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.32 |
| ▸ | PTPRF | P10586 | 2/20 | 0.32 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18252535 | 0.95 | ALOX5 (0.49) | ALOX5ATML3MBTL1KDM4EPRKDC | |
| SCHEMBL18252553 | 0.95 | ALOX5 (0.49) | ALOX5ATML3MBTL1KDM4EPRKDC | |
| SCHEMBL16596992 | 0.95 | ALOX5 (0.47) | ALOX5ATML3MBTL1KDM4EPRKDC | |
| SCHEMBL18252581 | 0.93 | ALOX5 (0.51) | ALOX5ATML3MBTL1KDM4EPRKDC | |
| SCHEMBL1635556 | 0.92 | ALOX5 (0.44) | ALOX5ATML3MBTL1KDM4EPRKDC | |
| SCHEMBL14882809 | 0.92 | ALOX5 (0.44) | ALOX5ATML3MBTL1KDM4EPRKDC | |
| SCHEMBL16482584 | 0.92 | ALOX5 (0.50) | ALOX5ATML3MBTL1KDM4EPRKDC | |
| SCHEMBL1637132 | 0.92 | ALOX5 (0.44) | ALOX5ATML3MBTL1KDM4EPRKDC | |
| SCHEMBL26725341 | 0.92 | ALOX5 (0.50) | ALOX5ATML3MBTL1KDM4EPRKDC | |
| SCHEMBL17249473 | 0.92 | ALOX5 (0.44) | ALOX5ATML3MBTL1KDM4EPRKDC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10256411-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-04-09 | — | — | US | disclosed |
| US-20170077409-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2017-03-16 | — | — | US | disclosed |
| US-20170077409-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2017-03-16 | — | — | US | disclosed |
| US-20160343951-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-11-24 | — | — | US | disclosed |
| US-20160343951-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160343951-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OSBP, OSBPL3, OSBPL8 | ALOX5 590/4885ATM 4208/4885L3MBTL1 953/4885 |
| US-20170077409-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OSBP, OSBPL3, OSBPL8 | ALOX5 590/4885ATM 4208/4885L3MBTL1 953/4885 |
| US-10256411-B2 | Organic electroluminescent materials and devices | OSBP, OSBPL3, OSBPL8 | ALOX5 590/4885ATM 4208/4885L3MBTL1 953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.